Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Susumu Sugai"'
Autor:
Yasufumi Masaki, Nozomu Kurose, Motohisa Yamamoto, Hiroki Takahashi, Takako Saeki, Atsushi Azumi, Shinji Nakada, Shoko Matsui, Tomoki Origuchi, Susumu Nishiyama, Kazunori Yamada, Mitsuhiro Kawano, Akira Hirabayashi, Keita Fujikawa, Tomoko Sugiura, Masanobu Horikoshi, Naoto Umeda, Hiroshi Minato, Takuji Nakamura, Haruka Iwao, Akio Nakajima, Miyuki Miki, Tomoyuki Sakai, Toshioki Sawaki, Takafumi Kawanami, Yoshimasa Fujita, Masao Tanaka, Toshihiro Fukushima, Katumi Eguchi, Susumu Sugai, Hisanori Umehara
Publikováno v:
International Journal of Rheumatology, Vol 2012 (2012)
IgG4-related disease is a new disease classification established in Japan in the 21st century. Patients with IgG4-related disease display hyper-IgG4-gammaglobulinemia, massive infiltration of IgG4+ plasma cells into tissue, and good response to gluco
Externí odkaz:
https://doaj.org/article/2c5a55b119ac482cbab259cb7a740320
Autor:
Yasuharu Sato, Keita Fujikawa, Shigeo Nakamura, Mitsuhiro Kawano, Ritsuro Suzuki, Masaru Kojima, Hiroaki Dobashi, Naoki Takahashi, Yasufumi Masaki, Shoko Matsui, Tadashi Yoshino, Yasunori Suzuki, Taiichiro Miyashita, Tomoyuki Sakai, Kazutaka Takagi, Yoshimasa Fujita, Hisanori Morimoto, Takafumi Kawanami, Toshihiro Fukushima, Hiroto Tsuboi, Shintaro Hirata, Yuko Morikawa, Haruka Iwao, Takayuki Sumida, Masatoshi Saito, Yoko Wada, Takako Saeki, Susumu Sugai, Nozomu Kurose, Masanobu Horikoshi, Tomoki Origuchi, Hiroshi Ogishima, Kentaro Susaki, Yoshiya Tanaka, Yasumori Izumi
Publikováno v:
Modern rheumatology. 27(5)
Although glucocorticoids are effective for patients with IgG4-related disease, the treatment has not yet been standardized. Therefore, the treatment strategy should be established.Patients who fulfilled the comprehensive diagnostic criteria for defin
Autor:
Susumu Sugai, Arundathi S. Malladi, Hisanori Umehara, Pekka Helin, Lindsey A. Criswell, Caroline H. Shiboski, Alan N. Baer, Yi Dong, John S. Greenspan, Stephen Shiboski, Frederick B. Vivino, Ratukondla Banushree, Kenneth E. Sack, Wen Zhang, Yan Zhao, Troy E. Daniels, Mengtao Li, Bruce Kirkham, C. Vollenweider
Publikováno v:
Arthritis care & research, vol 64, iss 6
Malladi, AS; Sack, KE; Shiboski, SC; Shiboski, CH; Baer, AN; Banushree, R; et al.(2012). Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care and Research, 64(6), 911-918. doi: 10.1002/acr.21610. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/1h62m7f3
Malladi, AS; Sack, KE; Shiboski, SC; Shiboski, CH; Baer, AN; Banushree, R; et al.(2012). Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care and Research, 64(6), 911-918. doi: 10.1002/acr.21610. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/1h62m7f3
Sjogren’s Syndrome (SS) is one of the most common autoimmune diseases, with an estimated prevalence of approximately 0.6% and a 20:1 female predilection (1, 2). SS may occur in isolation and has been referred to as primary Sjogren’s Syndrome (pSS
Publikováno v:
The Journal of Rheumatology. 39:1256-1264
Objective.Our previous studies indicated that CD40-mediated Fas-dependent apoptosis is important for the glandular destruction of Sjögren’s syndrome (SS), although other immune and nonimmune mechanisms are also involved in exocrine dysfunction. We
Autor:
Susumu Sugai, Hisanori Umehara, Frederick B. Vivino, Pekka Helin, S. Zhang, Morten Schiødt, Ava J. Wu, Genevieve Larkin, Kazuko Kitagawa, Stephen Challacombe, Yan Dong, Lindsey A. Criswell, Ana Maria Heidenreich, Mengtao Li, Nancy A. McNamara, Troy E. Daniels, Kenneth E. Sack, J Lindegaard, John S. Greenspan, John P. Whitcher, Bruce Kirkham, Stephen Shiboski, Alan N. Baer, W Zhang, Caroline H. Shiboski, P. J. Shirlaw, C. Vollenweider, Hector Lanfranchi, Deborah Greenspan, Yongju Zhao, Thomas M. Lietman
Publikováno v:
Arthritis Care & Research. 64:475-487
Objectives We propose new classification criteria for Sjogren’s Syndrome (SS), which are needed considering the emergence of biological agents as potential treatments and their associated co-morbidity. These criteria target individuals with signs/s
Publikováno v:
Current Immunology Reviews. 7:172-177
Autor:
Shigeyuki Kawa, Susumu Sugai
Publikováno v:
Current Immunology Reviews. 7:137-143
Autor:
Ichiei Narita, Yoko Wada, Takako Saeki, Shinji Nakada, Akira Hirabayashi, Hisanori Umehara, Shoko Matsui, Takuma Takata, Kana Miyazaki, Akihiko Saito, Tomoyuki Ito, Kunihiro Ishioka, Mitsuhiro Kawano, Hajime Yamazaki, Hiroki Takahashi, Yutaka Tsubata, Yasufumi Masaki, Sachiko Fukase, Shinichi Nishi, Naofumi Imai, Noriyuki Homma, Tomoki Origuchi, Susumu Sugai, Motohisa Yamamoto
Publikováno v:
Kidney International. 78(10):1016-1023
IgG4-related disease is a recently recognized multi-organ disorder characterized by high levels of serum IgG4 and dense infiltration of IgG4-positive cells into several organs. Although the pancreas was the first organ recognized to be affected by Ig
Publikováno v:
The Journal of Rheumatology. 37:1380-1385
Since the first report of serum IgG4 elevation in sclerosing pancreatitis in 2001, various systemic disorders have been reported to elevate IgG4, and many names have been proposed from the perspective of the systemic condition. Despite similarities i
Autor:
Troy E. Daniels, Hisanori Umehara, Hector Lanfranchi, Caroline H. Shiboski, Morten Schiødt, Lindsey A. Criswell, Stephen Shiboski, John S. Greenspan, Yi Dong, Stephen Challacombe, Susumu Sugai
Publikováno v:
Arthritis & Rheumatism. 61:711-714
Of the major autoimmune connective tissue diseases, Sjoren’s syndrome (SS) is perhaps the least well understood. Both primary and secondary forms of SS occur, but their phenotypes are not well defined. No less than 10 sets of diagnostic/classificat